Prolonged maternal magnesium administration and bone metabolism in neonates

Early Human Development

Volumn 86, Issue 3, 2010, Pages 187-191

  Yokoyama, Koji ^a   Takahashi, Naoto ^a   Yada, Yukari ^a   Koike, Yasunori ^a   Kawamata, Ryou ^a   Uehara, Ritei ^a   Kono, Yumi ^a   Honma, Yoko ^a   Momoi, Mariko Y ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Alkaline phosphatase; Bone abnormality; Magnesium sulfate; Neonate; Tocolysis

Indexed keywords

ALKALINE PHOSPHATASE; CALCIUM; MAGNESIUM; MAGNESIUM SULFATE; PHOSPHORUS;

ADULT; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; BONE DISEASE; BONE METABOLISM; BONE RADIOGRAPHY; CALCIUM BLOOD LEVEL; CASE CONTROL STUDY; CONTROLLED STUDY; DRUG EFFECT; FEMALE; FETUS; HUMAN; INFANT; LOADING DRUG DOSE; MAGNESIUM BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; METAPHYSIS; NEWBORN; OSTEOPENIA; PHOSPHATE BLOOD LEVEL; PREMATURE LABOR; RETROSPECTIVE STUDY;

ADULT; ALKALINE PHOSPHATASE; BIRTH WEIGHT; BONE AND BONES; BONE DEMINERALIZATION, PATHOLOGIC; BONE DENSITY; CALCIUM; CASE-CONTROL STUDIES; FEMALE; HUMANS; INFANT, NEWBORN; LOGISTIC MODELS; MAGNESIUM SULFATE; PHOSPHORUS; PREGNANCY; RETROSPECTIVE STUDIES;

EID: 77950341852     PISSN: 03783782     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.earlhumdev.2010.02.007     Document Type: Article

References (26)

1. Goldenberg R.L. The management of preterm labor. Obstet Gynecol 2002, 100(5):1020-1037.
2. McGuinness G.A., Weinstein M.M., Cruikshank D.P., Pitkin R.M. Effects of magnesium sulfate treatment on perinatal calcium metabolism. II. Neonatal responses. Obstet Gynecol 1980, 56(5):595-600.
3. Petrie R.H. Preterm parturition. Tocolysis using magnesium sulfate. Semin Perinatol 1981, 5:266-273.
4. Riaz M., Porat R., Brodsky N.L., Hurt H. The effects of maternal magnesium sulfate treatment on newborns: a prospective controlled study. J Perinatol 1998, 18(6 Pt 1):449-454.
5. Taber E.B., Tan L., Chao C.R., Beall M.H., Ross M.G. Pharmacokinetics of ionized versus total magnesium in subjects with preterm labor and preeclampsia. Am J Obstet Gynecol 2002, 186:1017-1021.
6. Kosasa T.S., Busse R., Wahl N., Hirata G., Nakayama R.T., Hale R.W. Long-term tocolysis with combined intravenous terbutaline and magnesium sulfate: a 10-year study of 1000 patients. Obstet Gynecol 1994, 84:369-373.
7. Dudley D., Gagnon D., Varner M. Long-term tocolysis with intravenous magnesium sulfate. Obstet Gynecol 1989, 73:373-378.
8. Harrison V., Fawcus S., Jordaan E. Magnesium Supplementation and perinatal hypoxia: outcome of a parallel group randomized trial in pregnancy. BJOG 2007, 114(8):994-1002.
9. Nelson K.B., Grether J.K. Can magnesium sulfate reduce the risk of cerebral palsy in very low birthweight infants?. Pediatrics 1995, 95:263-269.
10. Crowther C.A., Hiller J.E., Doyle L.W., Haslam R.R. Effect of magnesium sulfate given for neuroprotection before preterm birth: a randomized controlled trial. JAMA 2003, 290:2669-2676.
11. Marret S., Marpeau L., Zupan-Simunek V., Eurin D., Lévêque C., Hellt M.F., et al. Magnesium sulphate given before very-preterm birth to protect infant brain: the randomized controlled PREMAG trial. BJOG 2007, 114:310-318.
12. Marret S., Marpeau L., Bénichou J. Benefit of magnesium sulfate given before very preterm birth to protect infant brain. Pediatrics 2008, 121:225-226.
13. Marret S., Marpeau L., Follet-Bouhamed C., Cambonie G., Astruc D., Delaporte B., et al. Effect of magnesium sulphate on mortality and neurologic morbidity of the very-preterm newborn with two-year neurologic outcome: results of the prospective PREMAG trial. Gynecol Obstet Fertil 2008, 362:278-288.
14. Constantine M.M., Weiner S.J. Effects of antenatal exposure to magnesium sulfate on neuroprotection and mortality in preterm infants. Obstet Gynecol 2009, 114:354-364.
15. Rouse D.J., Hirtz D.G., Thom E., Varner M.W., Spong C.Y., Mercer B., et al. A randomized, controlled trial of magnesium sulfate for the prevention of cerebral palsy. N Engl J Med 2008, 359:895-905.
16. Lamm C.I., Norton K.I., Murphy R.J., Wilkins I.A., Rabinowitz J.G. Congenital rickets associated with magnesium sulfate infusion for tocolysis. J Pediatr 1988, 113:1078-1082.
17. Cumming W.A., Thomas V.J. Hypermagnesemia: a cause of abnormal metaphyses in the neonate. Am J Roentgenol 1989, 152:1071-1072.
18. Holcomb W.L., Shackelford G.D., Pitrie R.H. Magnesium tocolysis and neonatal bone abnormalities: a controlled study. Obstet Gynecol 1991, 78:611-614.
19. Santi M.D., Henry G.W., Douglas G.L. Magnesium sulfate treatment of preterm labor as a cause of abnormal neonatal bone mineralization. J Pediatr Orthop 1994, 14(2):249-253.
20. Schanler R.J., Smith L.G., Burns P.A. Effects of long-term maternal intravenous magnesium sulfate therapy on neonatal calcium metabolism and bone mineral content. Gynecol Obstet Invest 1997, 43:236-241.
21. Matsuda Y., Maeda Y., Ito M., Sakamoto H., Masaoka N., Takada M., et al. Effect of magnesium sulfate treatment on neonatal bone abnormalities. Gynecol Obstet Invest 1997, 44:82-88.
22. Levav A.L., Chan L., Wapner R.J. Long-term magnesium sulfate tocolysis and maternal osteoporosis in triplet pregnancy: a case report. Am J Perinatol 1998, 15:43-46.
23. Malaeb S.N., Rassi A.I., Haddad M.C., Seoud M.A., Yunis K.A. Bone mineralization in newborns whose mothers received magnesium sulphate for tocolysis of premature labour. Pediatr Radiol 2004, 34:384-386.
24. Tsukahara H., Kobata R., Tamura S., Mayumi M. Neonatal bone abnormalities attributable to maternal administration of magnesium sulfate. Pediatr Radiol [Letter] 2004, 34:673-674.
25. Nassar A.H., Sakhel K., Maarouf H., Naassan G.R., Usta I.M. Adverse maternal and neonatal outcome of prolonged magnesium sulfate tocolysis. Acta Obstet Gynecol 2006, 85:1099-1103.
26. Wedig K.E., Kogan J., Schorry E.K., Whitsett J.A. Skeletal demineralization and fractures caused by fetal magnesium toxicity. J Perinatol 2006, 26:371-374.